RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
158 hedge funds and large institutions have $1.48B invested in Revance Therapeutics, Inc. in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 56 increasing their positions, 43 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
11% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 18
32% less call options, than puts
Call options by funds: $7.13M | Put options by funds: $10.4M
Holders
158
Holding in Top 10
2
Calls
$7.13M
Puts
$10.4M
Top Buyers
| 1 | +$21M | |
| 2 | +$9.19M | |
| 3 | +$7.72M | |
| 4 |
BAMCO Inc
New York
|
+$7.2M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$5.4M |
Top Sellers
| 1 | -$43.3M | |
| 2 | -$24M | |
| 3 | -$4.92M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$4.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.41M |